Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
How Adaptimmune's T-Cell Therapy Development Pipeline Became a Commercialisation Success Story
Adaptimmune has developed from a strategic collaboration with GSK and embarked on a highly successful journey towards developing cancer immunotherapy treatments.
Antibody & Protein Engineering
Navigating the Pharma R&D Regulatory Landscape 2023
Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.
Drug Discovery & Development
European Commission Approves Genmab’s Subcutaneous Bispecific Antibody Tepkinly
The approval follows positive results from Genmab's 'Epcore' phase I/II clinical trial.
Oligo Chemistry
How Do Regulatory Considerations Impact the Clinical Development of Oligonucleotide Therapies?
What are the regulatory considerations that need to be made in the clinic for oligonucleotide therapies? What's the existing guidance for this emerging modality?
Peptide Chemistry
Trends and Challenges in Peptide Bioanalysis and Production
Here, we investigate some of the main trends and challenges in peptide bioanalysis such as non-specific binding, and look at how they can be circumvented.
Gene Therapy Development
Viral Vectors in Molecular Biology and Gene Therapy
Adeno-associated viral (AAV) vectors dominate gene therapy due to their efficiency and safety, although challenges remain in addressing toxicity and expanding applications.
Immuno-Oncology Vs Chemotherapy: Exploring Treatment Synergies
Unpacking the potential of combining immuno-oncology and chemotherapy: understanding benefits, real-world impact, and addressing concerns.